Zinc-mediated regulation of caspases activity: dose-dependent inhibition or activation of caspase-3 in the human Burkitt lymphoma B cells (Ramos)

被引:0
作者
N Schrantz
M-T Auffredou
M F Bourgeade
L Besnault
G Leca
A Vazquez
机构
[1] INSERM U.131 and Association Claude Bernard,
来源
Cell Death & Differentiation | 2001年 / 8卷
关键词
apoptosis; zinc; caspase; Burkitt lymphoma;
D O I
暂无
中图分类号
学科分类号
摘要
Divalent cations, including Zinc and Manganese ions, are important modulators of cell activation. We investigated the ability of these two divalent cations to modulate apoptosis in human Burkitt lymphoma B cells line (Ramos). We found that Zinc (from 10 to 50 μM) inhibited Manganese-induced caspase-3 activation and apoptosis of Ramos cells. Higher concentration of Zinc (50 to 100 μM) did not prevent Manganese-mediated apoptosis but rather increased cell death among Ramos cells. This Zinc-mediated cell death was associated with apoptotic features such as cell shrinkage, the presence of phosphatidylserine residues on the outer leaflet of the cells, chromatin condensation, DNA fragmentation and decrease of mitochondrial transmembrane potential. Zinc-mediated apoptosis was associated with caspase-9 and caspase-3 activation as revealed by the appearance of active p35 fragment of caspase-9 and p19 and p17 of caspase-3 as well as in vivo cleavage of PARP and of a cell-permeable fluorogenic caspase-3 substrate (Phiphilux-G1D2). Both Zinc-mediated apoptosis and caspase-3 activation were prevented by the cell-permeable, broad-spectrum inhibitor of caspases (zVAD-fmk) or overexpression of bcl-2. In addition, we show that Zinc-induced loss of transmembrane mitochondrial potential is a caspase-independent event, since it is not modified by the presence of zVAD-fmk, which is inhibited by overexpression of bcl-2. These results indicate that depending on its concentration, Zinc can exert opposite effects on caspase-3 activation and apoptosis in human B lymphoma cells: concentrations below 50 μM inhibit caspase-3 activation and apoptosis whereas higher concentrations of Zinc activate a death pathway associated with apoptotic-like features and caspase-3 activation.
引用
收藏
页码:152 / 161
页数:9
相关论文
共 264 条
  • [1] Cuajungco MP(1997)Zinc metabolism in the brain: relevance to human neurodegenerative disorders Neurobiol. Dis. 4 137-169
  • [2] Lees GJ(1993)Zinc status in pregnancy: the effect of zinc therapy on perinatal mortality, prematurity, and placental ablation Ann. NY Acad. Sci. 678 178-192
  • [3] Jameson S(1996)Apoptotic cell death in formation of vesicular skin lesions in patients with acquired zinc deficiency J. Cutan. Pathol. 23 359-363
  • [4] Mori H(1998)Improvement of the lymphoproliferative immune response and apoptosis inhibition upon in vitro treatment with zinc of peripheral blood mononuclear cells (PBMC) from HIV+ individuals Clin. Exp. Immunol. 111 264-268
  • [5] Matsumoto Y(1997)Zinc, again [editorial; comment] J. Rheumatol. 24 626-628
  • [6] Tamada Y(1996)Programmed cell death of peripheral myeloid precursor cells in Down patients: effect of zinc therapy Ultrastruct. Pathol. 20 457-462
  • [7] Ohashi M(1995)Micronutrients and HIV-1 disease progression Aids 9 1051-1056
  • [8] Neves Jr I(1995)Possible roles for glucocorticoids and apoptosis in the suppression of lymphopoiesis during zinc deficiency: a review J. Am. Coll. Nutr. 14 11-17
  • [9] Bertho AL(1997)The immunobiology of zinc [see comments] Immunol. Today 18 519-521
  • [10] Veloso VG(1997)Detection of apoptosis in peripheral blood cells of 31 subjects affected by Down syndrome before and after zinc therapy Ultrastruct. Pathol. 21: 449-452